| Literature DB >> 29582638 |
Bindhu Jayaprakash1, Arunava Das.
Abstract
Traditional plant medicines are used for a range of cancer conditions. The chickpea is highly proteinaceous and consumed as a staple in many parts of the world. An evaluation of chemoprotective and immunomodulatory activities of Cicer arietinum (CE) in cisplatin-induced immunosuppressed mice was here performed. Cisplatin was given at 100mg/kg, intraperitoneally, and after induction of immunosuppression mice were treated with Cicer arietinum (0.5 mg/dose/animal/IP) for a period of 10-day. The influence of the extract on lymphoid organ weight, bone marrow cellularity, alpha esterase activity and on enzyme levels such as (SGOT,SGPT, Urea, Creatinine was assessed to identify any chemoprotective influence. Administration of CE to cisplatin-treated mice alleviated the drastic reduction in bone marrow cellularity and α- esterase positive cells seen with cisplatin. Thus myelosuppression was reversed or inhibited. Cisplatin bids to DNA and causes damage resulting in chromosome breaks, micronucleus formation and cell death. CE is comprised of numerous middle-chain aliphatic alcohols, aldehydes and ketones, in addition to compounds like 7-hydroxy-1-methoxy-6-methylanthraquinone, cyclohexadecane (CAS) and 6-(amino methyl)-2-naphthol. These latter are thought to contribute to the characteristic aroma of C. arietimnum. In conclusion, administration of CE in cisplatin-treated mice, boosted bone marrow cellularity and increased α- esterase positive cells, thus reversing myelosupproession. Creative Commons Attribution LicenseEntities:
Keywords: Cicer arietinum; chemoprotective; cisplatin; alpha esterase; histopathology
Mesh:
Substances:
Year: 2018 PMID: 29582638 PMCID: PMC5980859 DOI: 10.22034/APJCP.2018.19.3.803
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Figure 1Phytochemical Standardization of Cicer arietinum by HPTLC
Preliminary Phytochemical Screening of C, arietinum Extract
| Test for Extract | Inference |
|---|---|
| Alkaloid | + |
| Flavanoid | + |
| Steroid | + |
| Terpenoid | + |
+, Presence; -, Absence
Figure 2GC-MS analysis of Cicer arietinum
Bioactive Components Identified in Methanolic Extract of C.arietinum by GC-MS Analysis
| S.No | Retention time (RT) | Rf Value | Name of the compound | Molecular formula | Molecular weight |
|---|---|---|---|---|---|
| 1 | 29.18 | 6.00,3 | 7-Hydroxy-1-methoxy-6-methylanthraquinone | C16H12O4 | 268 |
| 2 | 32.29 | 6.00,3 | 6-(Aminomethyl)-2-naphthol | C11H11NO | 173 |
| 3 | 13.78 | 6.00,3 | Cyclohexadecane (CAS) | C16H32 | 224 |
| 4 | 17.22 | 6.00,3 | (cis)-2-nonadecene | C19H38 | 266 |
| 5 | 20.99 | 6.00,3 | 1-formylbenzo[b]fluoranthene | C21H12O | 280 |
| 6 | 10.60 | 6.00,3 | 1-Tetradecene (CAS) | C14H28 | 196 |
| 7 | 24.54 | 6.00,3 | (cis)-2-nonadecene | C19H38 | 266 |
| 8 | 7.18 | 6.00,3 | 3-Dodecene, (Z)- | C12H24 | 168 |
Effect of C.arietinum on Relative Organ Weights in Cisplatin Treated Animals
| Treatment | Relative organ weight (g/100g body weight) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Spleen | Thymus | Liver | Kidney | Lungs | ||||||
| 7th day | 11thday | 7thday | 11thday | 7thday | 11thday | 7thday | 11thday | 7thday | 11thday | |
| Normal | 0.50± 0.11 | 0.69± 0.02 | 0.16± 0.04 | 0.18± 0.02 | 5.41± 0.38 | 5.98± 0.39 | 1.27± 0.17 | 1.26± 0.22 | 0.54± 0.03 | 0.59± 0.02 |
| Cisplatin alone | 0.23± 0.02 | 0.20± 0.04 | 0.17± 0.01 | 0.15± 0.07 | 3.78± 0.19 | 3.60± 0.40 | 1.23± 0.01 | 0.98± 0.04 | 0.62± 0.01 | 0.53± 0.03 |
| Cisplatin +Cicer arietimnum | 0.34±0.07** | 0.41±0.14** | 0.23±0.01** | 0.26±0.04* | 4.84±0.05* | 5.58±0.30* | 1.37±0.18* | 1.43±0.08** | 0.76±0.05* | 0.79±0.08* |
Values are expressed as mean ± SD,*p < 0.05, **p < 0.01, ***p <0.001.
Effect of C.arietinum on Bone Marrow Cellularity and αesterase Activity in Cisplatin Treated Animals
| Treatment | Bone Marrow Cellularity (Cells/femur) | α-Esterase activity (No. of α- esterase positive cells/4000 cells) | ||
|---|---|---|---|---|
| Days | 7th day | 11th day | 7th day | 11th day |
| Normal | 85.0×105 ±2.828 | 89.5×105 ±3.536 | 884± 2.828 | 892.5± 2.121 |
| Cisplatin alone | 25.5 × 105 ± 1.414 | 20.9×105 ± 3.055 | 634.5 ± 3.055 | 620.66 ± 3.055 |
| Cisplatin + Cicer arietimnum | 68.30×105± 4.242*** | 69.7×105± 4.950*** | 1179± 2.121*** | 1227± 1.414*** |
Values are expressed as mean ± SD,*p < 0.05,**p < 0.01, ***p <0.001
Effect of C.arietinum Treatment on the Serum, Liver SGOT Levels in Cisplatin Treated Animals
| Group | Serum GOT (IU/L) | Liver GOT (IU/L) | ||
|---|---|---|---|---|
| Days | 7th day | 11th day | 7th day | 11th day |
| Normal | 9.064 ± 0.3 | 9.172 ± 0.1 | 90.16 ± 2.9 | 97.41 ± 2.1 |
| Cisplatin alone | 76.92 ±1.8 | 82.28± 2.7 | 43.88 ± 2.3 | 32.67 ± 2.7 |
| Cisplatin + Cicer arietimnum | 55.93 ±0.1*** | 52.68± 0.4*** | 39.85± 0.7** | 41.54±1.3** |
Values are expressed as mean ± SD,*p < 0.05, **p < 0.01, ***p <0.001
Effect of C.arietinum Treatment on the Serum, Liver SGPT Levels in Cisplatin Treated Animals
| Group | Serum GPT (IU/L) | Liver GPT (IU/L) | ||
|---|---|---|---|---|
| Days | 7th day | 11th day | 7th day | 11th day |
| Normal | 9.390 ± 0.2 | 9.290 ± 0.04 | 69.45 ± 2.05 | 70.36±0.09 |
| Cisplatin alone | 74.65±1.4 | 85.22 ± 2.3 | 40.91±0.96 | 32.04±1.9 |
| Cisplatin + Cicer arieti mnum | 58.22±0.3** | 55.82±1.8*** | 45.22±0.9** | 48.29±1.4*** |
Values are expressed as mean ± SD,*p < 0.05, **p < 0.01, ***p <0.001
Effect of Cicer Arietimnum Treatment on the Serum Urea Levels in Cisplatin Treated Animals
| Group | Serum(mg/dL) Urea concentration (mg/dL) | BUN concentration (mg/dL) | ||
|---|---|---|---|---|
| Days | 7th day | 11th day | 7th day | 11th day |
| Normal | 28.41±1.1 | 31.19±1.4 | 13.26±0.5 | 14.56±0.6 |
| Cisplatin alone | 17.54±0.4 | 4.71 ±0.09 | 8.19 ±0.20 | 2.20 ±0.04 |
| Cisplatin + Cicer arietimnum | 15.01± 0.2*** | 15.04 ± 0.12*** | 7.00 ±0.12*** | 7.02 ±0.05*** |
Values are expressed as mean ± SD,*p < 0.05, **p < 0.01, ***p <0.001
Effect of C.arietinum Treatment on the Serum, Liver Creatinine Levels in Cisplatin Treated Animals
| Group | Serum(mg/dL) | |
|---|---|---|
| Days | 7th day | 11th day |
| Normal | 1.750 ± 0.04 | 1.880 ± 0.04 |
| Cisplatin alone | 1.438 ±0.09 | 1.457 ±0.08 |
| Cisplatin + Cicer arietimnum | 1.075 ± 0.04*** | 0.920± 0.05*** |
Values are expressed as mean ± SD, *p < 0.05, **p < 0.01, ***p <0.001
Figure 4Histopathological Changes in Liver of Cisplatin Induced Immunosuppressed Mice
Figure 3Histopathological Changes in Liver of Normal Healthy Control Mice
Figure 5Histopathological Changes in Liver of Cicer Arietinum Treated Mice